PT-141
aka Bremelanotide
Melanocortin
Mechanism
PT-141 (Bremelanotide) is a cyclic heptapeptide melanocortin receptor agonist derived from Melanotan II. It is FDA-approved as Vyleesi (2019) for hypoactive sexual desire disorder in premenopausal women only.
Identification
Vendors selling PT-141
No vendor listings on file yet.
Research
No citations on file yet.